JNJJOHNSON & JOHNSONSEC EDGAR
Use with Claude or ChatGPT
  • Overview
  • Income statement
  • Balance sheet
  • Cash flow
  • Earnings

JOHNSON & JOHNSON (JNJ) Earnings history

8 quarters held7/8 transcripts analyzed2/40 figures attestedNext: Dec 8, 2026, 8:30 AM
Ask your agent: get_earnings
PeriodRevenueYoYNet incomeEPS (dil.)Filed
Q3 2026$25.4B+5.9%$210.0M$0.09Oct 13, 2026
LATESTEarnings filing (8-K)10-QFiled Oct 13, 2026, 8:12 AM ET
Earnings call · Oct 13, 2026deckdeckwebcast
Q3 FY26YoY9M FY26
Revenue$25.4B1+5.9%$74.8B
Net income$210.0M-95.9%$11.0B
Op income–––
EPS (dil.)$0.09–$4.49
EPS (basic)–––
Gross margin68.1%-1.5pp
Net margin0.8%-20.6pp
  1. [1] “Sales to customers | $ | 25,399 | 100.0 | | $ | 23,993 | 100.0 | | 5.9” view source

Guidance & outlook

Management guidance

Q3 2026

fy_current

revenue
$101.2B—$101.2B
eps_diluted
$11.10—$11.10

Special items & operational metrics

Operational metrics

Q3 2026

LLM-extracted from the earnings release; unverified.

Metric Name
N/A
Q2 2026$25.3B+6.6%$5.5B$2.27Jul 16, 2026
Earnings filing (8-K)10-QFiled Jul 15, 2026, 7:49 AM ET
Earnings call · Jul 15, 2026transcriptView originalprepared remarksQ&Adeckdeckwebcast
Q2 FY26YoY6M FY26
Revenue$25.3B1+6.6%$49.4B
Net income$5.5B-0.1%$10.8B
Op income$6.7B––
EPS (dil.)$2.27–$4.41
EPS (basic)–––
Gross margin68.2%+0.3pp
Op margin26.7%–
Net margin21.9%-1.4pp
  1. [1] “Sales to customers $ 25,310 100.0 $ 23,743 100.0 6.6” view source
Q1 2026$24.1B+9.9%$5.2B$2.14Apr 14, 2026
Earnings filing (8-K)10-QFiled Apr 14, 2026, 7:35 AM ET
Earnings call · Apr 14, 2026transcriptView originalprepared remarksQ&Adeckwebcast
Q1 FY26YoY
Revenue$24.1B+9.9%
Net income$5.2B-52.4%
Op income$6.0B-56.1%
EPS (dil.)$2.14-52.9%
EPS (basic)––
Gross margin66.3%-0.1pp
Op margin24.9%-37.4pp
Net margin21.8%-28.4pp
Q4 2025$24.6B+9.1%$5.1B$2.10Jan 21, 2026
Earnings filing (8-K)10-KFiled Jan 21, 2026, 7:46 AM ET
Earnings call · Jan 21, 2026transcriptView originalprepared remarksQ&Adeckwebcast
Q4 FY25YoYFY25
Revenue$24.6B+9.1%$94.2B
Net income$5.1B+49.1%$26.8B
Op income–––
EPS (dil.)$2.10+48.9%$11.03
EPS (basic)–––
Q3 2025$24.0B+6.8%$5.2B$2.12Oct 14, 2025
Earnings filing (8-K)10-QFiled Oct 14, 2025, 7:22 AM ET
Earnings call · Oct 14, 2025transcriptView originalprepared remarksQ&Adeckwebcast
Q3 FY25YoY
Revenue$24.0B+6.8%
Net income$5.2B+91.2%
Op income––
EPS (dil.)$2.12+91.0%
EPS (basic)––
Q2 2025$23.7B+5.8%$5.5B$2.29Jul 16, 2025
Earnings filing (8-K)10-QFiled Jul 16, 2025, 8:06 AM ET
Earnings call · Jul 16, 2025transcriptView originalprepared remarksQ&Adeckwebcast
Q2 FY25YoY6M FY25
Revenue$23.7B+5.8%$93.4B
Net income$5.5B+18.2%–
Op income–––
EPS (dil.)$2.29+18.7%$10.85
EPS (basic)–––
Q1 2025$21.9B+2.4%$11.0B$4.54Apr 15, 2025
Earnings filing (8-K)10-QFiled Apr 15, 2025, 8:14 AM ET
Earnings call · Apr 15, 2025transcriptView originalprepared remarksQ&Adeckwebcast
Q1 FY25YoY
Revenue$21.9B+2.4%
Net income$11.0B+237.9%
Op income––
EPS (dil.)$4.54+238.8%
EPS (basic)––
Q4 2024$22.5B+5.3%$3.4B$1.41Jan 22, 2025
Earnings filing (8-K)10-KFiled Jan 22, 2025, 6:35 AM ET
Earnings call · Jan 22, 2025transcriptView originalprepared remarksQ&Adeckwebcast
Q4 FY24YoYFY24
Revenue$22.5B+5.3%$88.8B
Net income$3.4B-17.0%$14.1B
Op income–––
EPS (dil.)$1.41-17.1%$5.79
EPS (basic)–––

IR event calendar

Upcoming
  • Johnson & Johnson 2026 Enterprise Business ReviewDec 8, 2026, 8:30 AM
    documentdocument
Past
  • Johnson & Johnson Third Quarter 2026 Earnings CallOct 13, 2026, 8:30 AM
    webcastpresentationpresentationpress_releasetranscriptwebcast
  • Deutsche Bank Healthcare SummitSep 17, 2026, 12:00 PM
    webcastpress_releasetranscriptwebcast
  • Morgan Stanley 24th Annual Global Healthcare ConferenceSep 14, 2026, 11:30 AM
    webcastpress_releasetranscriptwebcast
  • Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare ConferenceSep 9, 2026, 11:00 AM
    webcastpress_releasetranscriptwebcast
  • Johnson and Johnson OTTAVA Investor CallAug 3, 2026, 8:00 AM
    webcastpress_releasetranscriptwebcast
  • SRS ConferenceJul 22, 2026
    webcast

+66 more

IR event calendar last checked 2026-11-14 20:00:35+00; events announced since are not shown.

Filing coverage

64 filings indexed · 97,114 XBRL facts
FilingDatePeriodSectionsTables
10-Q2026-10-21–29121
8-K2026-10-13Q3 2026100
8-K2026-08-04–30
8-K2026-07-29–10
8-K2026-07-28–10
10-Q2026-07-23–29122
8-K2026-07-15–110
8-K2026-04-28–10
10-Q2026-04-22–3067
8-K2026-04-14–130

Showing the latest 10 of 64 — the full set is in the API.

Related Research

Analysis

The $15 Billion Earnings Illusion Inside AbbVie's 10-K